Rise in drug-resistant infections, particularly CPOs.
CDC report emphasizes need for enhanced laboratory detection.
NDM now exceeds KPC as most common carbapenemase.
Importance of mechanism-guided therapy highlighted.
Labs must utilize specific testing methods for effective detection.
Collaboration between microbiologists and infection teams is essential.
Facilities should prioritize resistance testing to adapt to evolving patterns.
Newsletters
Receive the latest pathologist news, personalities, education, and career development – weekly to your inbox.
